$168.49 0.1%
ABBV Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About AbbVie

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Price $168.49
Target Price Sign up
Volume 430,490
Market Cap $301B
Year Range $135.01 - $180.38
Dividend Yield 3.64%
PE Ratio 50.83
Revenue per Employee $1,088,060
Earnings Date July 25 '24
Industry Drug Manufacturers

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2412.3B9.31B3B1.37B4.31B2.310
Q4 '2314.3B5.7B8.6B822M3.62B2.790
Q3 '2313.9B11.9B2.07B1.78B4.51B2.950
Q2 '2313.9B9.61B4.26B2.02B5.26B2.910
Q1 '2312.2B9.68B2.54B239M2.97B2.460

Insider Transactions View All

Donoghoe Nicholas filed to sell 55,903 shares at $176.3.
March 22 '24
Stewart Jeffrey Ryan filed to sell 88,681 shares at $179.
March 20 '24
Stewart Jeffrey Ryan filed to sell 93,780 shares at $178.9.
March 20 '24
Stewart Jeffrey Ryan filed to sell 60,941 shares at $178.7.
March 20 '24
RICHMOND TIMOTHY J. filed to sell 33,964 shares at $176.4.
March 5 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Jun 5, 24 Sell $1K - $15K
Rohit Khanna
May 6, 24 Sell $1K - $15K
William Keating
May 2, 24 $15K - $50K

What is the Market Cap of AbbVie?

The Market Cap of AbbVie is $301B.

What is AbbVie's PE Ratio?

As of today, AbbVie's PE (Price to Earnings) ratio is 50.83.

How Many People Work at AbbVie?

As of our latest update, AbbVie employed approximately 50,000 people worldwide. However, it's important to note that AbbVie's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is AbbVie's revenue per employee?

$1,088,060. To calculate AbbVie's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does AbbVie report earnings?

AbbVie will report its next earnings on July 25 '24.

What is the current stock price of AbbVie?

Currently, the price of one share of AbbVie stock is $168.49.

How can I analyze the ABBV stock price chart for investment decisions?

The ABBV stock price chart above provides a comprehensive visual representation of AbbVie's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling AbbVie shares. Our platform offers an up-to-date ABBV stock price chart, along with technical data analysis and alternative data insights.

Does ABBV offer dividends to its shareholders?

Yes, AbbVie (ABBV) offers dividends to its shareholders, with a dividend yield of 3.64%. This dividend yield represents AbbVie's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering AbbVie in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of AbbVie?

Some of the similar stocks of AbbVie are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and TherapeuticsMD.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.